Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 20.07
+0.79 (4.10%)
Sep 30, 2026, 3:00 PM CST
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 8.1 billion as of October 2, 2026. Its market cap has decreased by -11.25% in one year.
Market Cap
8.10B
Enterprise Value
8.35B
Revenue
1.70B
Ranking
n/a
PE Ratio
22.02
Stock Price
20.07
ChartMarket Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 8.10B, an increase of 67.56%. That is a compound annual growth rate of 8.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 8.10B | -20.43% |
| Dec 31, 2025 | 10.18B | 18.61% |
| Dec 31, 2024 | 8.58B | -18.20% |
| Dec 29, 2023 | 10.49B | 4.58% |
| Dec 30, 2022 | 10.03B | 13.58% |
| Dec 31, 2021 | 8.83B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 9.28B |
| Chengdu Easton Biopharmaceuticals | 8.88B |
| Vcanbio Cell & Gene Engineering Corp., | 8.85B |
| Bio-Thera Solutions | 8.71B |
| Liaoning Chengda Biotechnology | 8.64B |
| Beijing Hotgen Biotech | 8.33B |
| Daan Gene | 8.07B |
| Novogene | 8.01B |